Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Prof Irene Roberts, recipient of the European Hematology Association (EHA) Education & Mentoring Award 2019.

The annual EHA award honours “those whose outstanding contributions to hematology education deserve acknowledgment and acclaim”. Prof Roberts was announced as the winner of this year’s award, in conjunction with Shaun McCann, at the European Haematological Society Congress, which took place in Amsterdam between the 13th and the 16th of June.

Prof Anindita Roy, Associate Professor of Paediatric Haematology, said about the award “Irene has been an incredible mentor and role model to me and I have been very lucky to have her unfailing support and guidance throughout my research career. Her selfless dedication to training and nurturing the next generation of clinician scientists is truly inspirational, and I am so pleased that she has been awarded the European Haematology Association's Education and Mentoring award. It is hugely deserved and I can think of no better recipient."

Irene Roberts has been Professor of Paediatric Haematology in the Department of Paediatrics since October 2013. She was previously Professor of Paediatric Haematology at Imperial College London. She is also a Group Leader at the MRC Molecular Haematology Unit. She has a longstanding interest in the impact of trisomy 21 on haematopoiesis and her group studies how the biological and molecular properties of fetal stem and progenitor cells provide the permissive cellular context for leukaemia in early childhood.

Similar stories

Professor Matthew Snape named NIHR Senior Investigator

Awards & Appointments Vaccinology

Four academics supported by the NIHR Oxford Biomedical Research Centre have been awarded a prestigious national award, among them Matthew Snape from the Oxford Vaccine Group.

University spinout PepGen awarded major financing to target Duchenne muscular dystrophy

Awards & Appointments Neuromuscular Diseases

PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.

Enriching Engagement (Round 2) awardees announced

Awards & Appointments Neuromuscular Diseases Public Engagement

The awardees for the second round of the University of Oxford’s Enriching Engagement funding scheme have now been announced, including a project from Paediatrics.

Typhoid vaccine project wins Vice-Chancellor award

Awards & Appointments Vaccinology

Congratulations to Professor Andrew Pollard who is the Winner of the Policy Engagement category in the Vice-Chancellor Innovation Awards 2020 for his work on Global policy on typhoid vaccines through research at Oxford!

Paediatrics project receives funding to assess novel coronavirus infection rates in children and teenagers across the UK

Awards & Appointments COVID-19 Vaccinology

A multi-site project, called ‘What’s the STORY?’ has received funding from UK Research and Innovation (UKRI) to assess novel coronavirus infection rates in children and teenagers across the UK. Given the importance of this study to the national Covid-19 response it has been deemed a priority study for the National Institute for Health Research’s (NIHR) Urgent Public Health Response.

Funding for new COVID-19 studies awarded to OVG's project on infectious disease immunity in children

Awards & Appointments COVID-19 Research Vaccinology

Five projects from across Oxford University's Medical Sciences Division, including a project led by Professor Matthew Snape from the Oxford Vaccine Group, are among twenty-one new studies into the novel coronavirus which have been funded by the UK government.